Michael R Hayden Insider Trading $XENE Xenon Pharmaceuticals Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael R Hayden.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael R Hayden. Michael R Hayden is Director in IONIS PHARMACEUTICALS INC ($ISIS) and Director in Xenon Pharmaceuticals Inc. ($XENE) and Director in Aurinia Pharmaceuticals Inc. ($AUPH) and Director in AbCellera Biologics Inc. ($ABCL) and Director in 89bio, Inc. ($ETNB).
Michael R Hayden in Xenon Pharmaceuticals Inc.
Trading Symbol: XENEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael R Hayden: Director
Holdings: 50,924 shares
Current Value: $417,577
Latest Transaction: Jun 02 2020
$XENE Market Capitalization: $145.83M
$XENE Previous Close: $8.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael R Hayden in Xenon Pharmaceuticals Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, ABCL, AUPH, ISIS, XENE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2020 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 13.11 | 10,000 | 131,100 | 10,000 | |
Sep 18 2019 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
Mar 20 2019 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.38 | 20,576 | 69,547 | 0 | |
Mar 20 2019 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.38 | 20,576 | 69,547 | 50,924 | 30.3 K to 50.9 K (+67.80 %) |
Mar 12 2019 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Gift | G | 0.00 | 17,337 | 0 | 114,403 | 97.1 K to 114.4 K (+17.86 %) |
Mar 12 2019 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Gift | G | 0.00 | 24,045 | 0 | 107,562 | 131.6 K to 107.6 K (-18.27 %) |
Jun 05 2018 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 6.20 | 15,000 | 93,000 | 15,000 | |
Mar 01 2018 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Gift | G | 0.00 | 21,180 | 0 | 97,066 | 75.9 K to 97.1 K (+27.91 %) |
Mar 01 2018 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Gift | G | 0.00 | 29,580 | 0 | 131,607 | 161.2 K to 131.6 K (-18.35 %) |
Aug 14 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | P | 2.75 | 15,000 | 41,247 | 161,187 | 146.2 K to 161.2 K (+10.26 %) |
Jun 02 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 3.85 | 3,500 | 13,475 | 3,500 | |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.56 | 3,086 | 10,986 | 0 | |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.07 | 4,629 | 14,211 | 0 | |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.77 | 4,115 | 15,514 | 0 | |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.67 | 5,144 | 18,878 | 0 | |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.76 | 25,720 | 96,707 | 0 | |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.70 | 18,004 | 66,615 | 0 | |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.56 | 3,086 | 10,986 | 30,348 | 27.3 K to 30.3 K (+11.32 %) |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.07 | 4,629 | 14,211 | 27,262 | 22.6 K to 27.3 K (+20.45 %) |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.77 | 4,115 | 15,514 | 22,633 | 18.5 K to 22.6 K (+22.22 %) |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.67 | 5,144 | 18,878 | 146,187 | 141 K to 146.2 K (+3.65 %) |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.76 | 25,720 | 96,707 | 141,043 | 115.3 K to 141 K (+22.30 %) |
Mar 15 2017 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.70 | 18,004 | 66,615 | 115,323 | 97.3 K to 115.3 K (+18.50 %) |
Jun 03 2016 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 7.38 | 3,500 | 25,830 | 3,500 | |
May 27 2016 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | M | 3.30 | 8,230 | 27,159 | 0 | |
May 27 2016 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | M | 3.30 | 8,230 | 27,159 | 18,518 | 10.3 K to 18.5 K (+80.00 %) |
May 06 2015 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 13.48 | 3,086 | 41,599 | 3,086 | |
Nov 12 2014 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | C | 0.00 | 1,504 | 0 | 0 | |
Nov 12 2014 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | C | 0.00 | 2,693 | 0 | 0 | |
Nov 12 2014 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | C | 0.00 | 10,030 | 0 | 0 | |
Nov 12 2014 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | C | 0.00 | 1,504 | 0 | 75,886 | 74.4 K to 75.9 K (+2.02 %) |
Nov 12 2014 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | C | 0.00 | 2,693 | 0 | 74,382 | 71.7 K to 74.4 K (+3.76 %) |
Nov 12 2014 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Buy | C | 0.00 | 10,030 | 0 | 71,689 | 61.7 K to 71.7 K (+16.27 %) |
Nov 06 2014 | XENE | Xenon Pharmaceutic ... | Hayden Michael R | Director | Option Exercise | A | 9.00 | 5,144 | 46,296 | 5,144 |
Page: 1